New medical research is shedding light on cancer risks and treatment options, with studies examining both potential causes and ways to reduce unnecessary treatments.

A recent study has identified a potential link between insomnia and cancer risk in younger women. Researchers found that women under 50 who suffer from sleep disorders may face an increased likelihood of developing certain types of cancer, though the exact mechanisms behind this association require further investigation.

Separately, advances in genetic testing are showing promise for breast cancer treatment. A study following over 4,400 patients aged 40 and older examined the effectiveness of the Prosigna gene test in determining treatment approaches. The research found that patients whose tumors scored low on the Prosigna test received little to no additional benefit from chemotherapy.

The findings suggest that genetic testing could help identify breast cancer patients who may be able to avoid chemotherapy while maintaining similar outcomes. This could potentially spare many patients from the side effects and complications associated with chemotherapy treatment.

These developments come as medical researchers continue to explore both risk factors for cancer development and ways to personalize treatment based on individual patient characteristics and tumor genetics.